✦ LIBER ✦

Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma

✍ Scribed by M. Joerger; A. D. R. Huitema; P. L. Meenhorst; J. H. M. Schellens; J. H. Beijnen

Publisher: Springer
Year: 2005
Tongue: English
Weight: 390 KB
Volume: 55
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-004-0900-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter trial of low-dose paclitaxel

Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma

✍ Anil Tulpule; Jerome Groopman; M. Wayne Saville; William Harrington Jr.; Alvin F 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

## Abstract ## BACKGROUND Treatment options are limited for patients with advanced acquired immunodeficieny syndrome (AIDS)‐related Kaposi sarcoma (AIDS‐KS) whose disease has progressed after receiving therapy with liposomal anthracyclines or combination chemotherapy with doxorubicin (Adriamycin),

Phase I dose escalation pharmacokinetics

Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's sarcoma

✍ Jeff D. Moore; Bruce J. Dezube; Parkash Gill; Xiao-Jian Zhou; Edward P. Acosta; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 118 KB

Pharmacokinetics and efficacy of low-dos

Pharmacokinetics and efficacy of low-dose methotrexate in patients with rheumatoid arthritis

✍ Yoshiko Hiraga; Yoshimitsu Yuhki; Katsumi Itoh; Kohji Tadano; Yasushi Takahashi; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 347 KB

Phase 1/2 trial of BMS-275291 in patient

Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma : A multicenter trial of the AIDS Malignancy Consortium

✍ Brett T. Brinker; Susan E. Krown; Jeannette Y. Lee; Ethel Cesarman; Amy Chadburn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract ## BACKGROUND. Matrix metalloproteinases (MMPs) are overexpressed in Kaposi sarcoma (KS). The safety and efficacy of a novel, orally bioavailable MMP inhibitor, BMS‐275291, was evaluated in patients with human immunodeficiency virus‐associated KS and the correlation between changes in

Pegylated liposomal doxorubicin as secon

Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma : A retrospective study

✍ Giuseppe Di Lorenzo; Rossella Di Trolio; Vincenzo Montesarchio; Giovanna Palmier 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND. Classic Kaposi sarcoma (CKS) is a rare neoplasm that predominantly occurs in elderly subjects and has a variable clinical evolution. The clinical course is usually indolent, but occasionally the neoplasm progresses rapidly and spreads to internal organs, necessitating sy

Retrospective, longitudinal analysis of

Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related kaposi's sarcoma patients before and after diagnosis

✍ Abeltje M. Polstra; Marion Cornelissen; Jaap Goudsmit; Antoinette C. van der Kuy 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

## Abstract Human herpesvirus 8 (HHV‐8) is detected more often in patients progressing towards Kaposi's sarcoma (KS) than in patients who do not develop the disease, suggesting that the level of viremia might be associated with Kaposi's sarcoma disease and progression. Longitudinal serum samples fr